$56.55
7.30% today
Nasdaq, Dec 01, 09:46 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US04280A1007
Symbol
ARWR

Arrowhead Pharmaceuticals, Inc. Stock price

$52.70
+13.15 33.25% 1M
+37.14 238.69% 6M
+33.90 180.32% YTD
+26.55 101.53% 1Y
+24.70 88.21% 3Y
-9.83 15.72% 5Y
+46.38 733.86% 10Y
+15.80 42.82% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
-5.01 8.68%

New AI Insights on Arrowhead Pharmaceuticals, Inc. Insights AI Insights on Arrowhead Pharmaceuticals, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$7.2b
Enterprise Value
$6.9b
Net debt
positive
Cash
$898.2m
Shares outstanding
138.1m
Valuation (TTM | estimate)
P/E
negative | 697.4
P/S
12.5 | 9.4
EV/Sales
12.0 | 9.0
EV/FCF
negative
P/B
13.7
Financial Health
Equity Ratio
16.3%
Return on Equity
-323.3%
ROCE
-9.1%
ROIC
-26.0%
Debt/Equity
1.1
Financials (TTM | estimate)
Revenue
$573.0m | $759.5m
EBITDA
$-85.2m | $82.8m
EBIT
$-107.8m | $59.1m
Net Income
$-148.9m | $10.4m
Free Cash Flow
$-17.1m
Growth (TTM | estimate)
Revenue
2,815.9% | 21,293.2%
EBITDA
83.9% | 114.2%
EBIT
80.3% | 109.8%
Net Income
72.4% | 101.7%
Free Cash Flow
96.8%
Margin (TTM | estimate)
Gross
-
EBITDA
-14.9% | 10.9%
EBIT
-18.8%
Net
-26.0% | 1.4%
Free Cash Flow
-3.0%
More
EPS
$-1.1
FCF per Share
$-0.1
Short interest
10.8%
Employees
609
Rev per Employee
$10.0k
Show more

Is Arrowhead Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Arrowhead Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Arrowhead Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
573 573
2,816% 2,816%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 122 122
14% 14%
21%
- Research and Development Expense 536 536
21% 21%
93%
-85 -85
84% 84%
-15%
- Depreciation and Amortization 23 23
29% 29%
4%
EBIT (Operating Income) EBIT -108 -108
80% 80%
-19%
Net Profit -149 -149
72% 72%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Arrowhead Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arrowhead Pharmaceuticals, Inc. Stock News

Neutral
Business Wire
27 minutes ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Piper Sandler 37th Annual Healthcare Conference – December 2-4, 2025 Type: Fireside Chat Presentation Date/Time: December 3, 2025, 10:30 a.m. EST 8th Annual Evercore Healthcare Conference – December 2-4, 2025 Type: Fire...
Neutral
Seeking Alpha
2 days ago
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Neutral
Seeking Alpha
4 days ago
Arrowhead Pharmaceuticals, Inc. ( ARWR ) TD Cowen Treatment Advancements in Obesity and Related Disorders Summit November 24, 2025 1:30 PM EST Company Participants James Hamilton - Chief Medical Officer and Head of R&D Conference Call Participants Joseph Thome - TD Cowen, Research Division Presentation Joseph Thome TD Cowen, Research Division Everyone, and thank you for joining us at TD Cowen's...
More Arrowhead Pharmaceuticals, Inc. News

Company Profile

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Head office United States
CEO Christopher Anzalone
Employees 609
Founded 1989
Website arrowheadpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today